Quality control (QC) of biospecimens from oral and maxillofacial tumors patients constitutes a critical foundation for the prevention, diagnosis, treatment, and precision medicine research of these diseases. Biospecimen quality directly governs the discovery and validation of disease biomarkers, the elucidation of pathogenesis, and the efficacy of clinical translation. QC spans the entire biospecimen lifecycle—encompassing collection, processing, storage, transportation, and utilization. Its primary objectives are to ensure sample integrity, reliability, traceability, and consistency, thereby guaranteeing the robustness of research data; the accuracy of molecular subtyping, biomarker identification, and treatment response prediction; and the precision of clinical decision-making. However, current QC frameworks for these biospecimens remain underdeveloped. Drawing on domestic and international technical standards, regulatory guidelines, and recent research advances, this paper elaborates on the importance of implementing a QC management system throughout the biospecimen lifecycle. It focuses on QC methodologies tailored to diverse biospecimen types, examining how standardized sampling procedures, regulated preprocessing workflows, and optimized long-term storage conditions influence sample quality. We aim to provide concrete guidance and a transferable paradigm for establishing standardized QC protocols and an informatics-enabled traceability system specific to oral and maxillofacial tumors. Such efforts are intended to enhance the research value and clinical utility of these biospecimens, furnishing reliable sample resources and technical support for the development of precision diagnostics and therapeutics. Furthermore, we advocate for a dual-track “QC plus Ethics” management framework within biobanks. This approach would reinforce ethical and legal safeguards, establishing a robust barrier to support safe scientific innovation and clinical translation.

Objective To explore new therapeutic strategies for periodontitis, this study prepared extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUC-MSCs) loaded with saikosaponin D (SSD) and evaluated their efficacy in a mouse model of periodontitis. Methods This study was approved by the Medical Ethics Committee and the Laboratory Animal Ethics Committee of the unit. hUC-MSCs at logarithmic growth phase were seeded into 96 well plates and then treated with various concentrations of SSD for 24 hours. The CCK-8 assay was used to determine the SSD concentration that preserves hUC-MSC viability. Flow cytometry (FCM) assessed SSD-induced apoptosis in hUC-MSCs and determined drug loading and loading efficiency. Nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM) characterized the morphology and size of hUC-MSCs-EVs and hUC-MSCs-SSD-EVs. C57BL/6J mice were divided into five groups with six mice per group: control group, periodontitis model group (PD), PD+SSD group (2 mg/kg), PD+hUC-MSCs-EVs group (10 μg/μL) and PD+hUC-MSCs-SSD-EVs group (10 μg/μL). Administration was performed 3 times a week for 4 consecutive weeks. Micro-CT and hematoxylin-eosin (HE) staining evaluated alveolar bone resorption in periodontal tissues of a mouse model of periodontitis. RT-qPCR measured inflammatory cytokine expression in periodontal tissues of a mouse model of periodontitis. Immunofluorescence analyzed macrophage M1/M2 polarization and runt-related transcription factor 2 (RUNX2) protein expression in periodontal tissues of a mouse model of periodontitis. Results The CCK-8 assay showed that 10 μmol/L SSD had little effect on hUC-MSCs viability (P>0.05). FCM confirmed the successful loading of SSD into EVs with a loading efficiency of 11.40%. TEM and NTA revealed that hUC-MSCs-SSD-EVs presented round or oval membranous structures with diameters ranging from 200 to 300 nm. Micro CT and HE staining showed that, compared with the PD group, the distance from cementoenamel junction to alveolar bone crest (CEJ-ABC) was markedly shortened (P<0.01）.The alveolar bone of periodontitis‑model bone volume fraction (BV/TV) and trabecular number (Tb.N) were significantly elevated in the PD+hUC-MSCs-SSD-EVs group (P<0.01). RT-qPCR and IF results showed that hUC-MSCs-SSD-EVs in periodontal tissues markedly downregulated the expression of pro-inflammatory cytokines including interleukin-1β, interleukin-6, tumor necrosis factor-α, interleukin-12 and interleukin-22 (P<0.01), upregulated the expression of the anti-inflammatory factor interleukin-10 (P<0.01), promoted the polarization of macrophages from the M1 phenotype to the M2 phenotype, and elevated the protein expression level of RUNX2 (P<0.01). Conclusion hUC-MSC-SSD-EVs effectively alleviated inflammatory responses in a mouse model of maxillary periodontitis and reduced alveolar bone loss, providing a new idea for the treatment of periodontitis.

Objective To investigate the effect of injectable tetra-polyethylene glycol (PEG) hydrogels loaded with sitagliptin (STG) (abbreviated as PEG-STG hydrogels) on skin wound healing in diabetic mice, providing an experimental basis for the subsequent development of local therapeutic materials for primary healing of oral and maxillofacial skin and soft tissue wounds in patients with diabetes. Methods PEG hydrogels were fabricated via the reaction of four-arm PEG succinimidyl glutarate (PEG-SG) and four-arm PEG amine (PEG-NH₂). Subsequently, PEG hydrogels loaded with STG were prepared. The microstructure, gelation, injectability, compression properties, swelling, degradation, and in vitro drug release profiles were characterized. In vitro cellular experiments were conducted using the mouse fibroblast cell line L929 and human umbilical vein endothelial cells (HUVECs), which were divided into four groups: an NC group (normal medium control), Glu group (30 mmol/L high glucose medium), PEG group (high glucose medium with PEG hydrogel extracts), and PEG-STG group (high glucose medium with PEG-STG hydrogel extracts). Biocompatibility was evaluated via CCK-8 assays, live/dead staining, and hemolysis tests. The impact of the PEG-STG hydrogels on cellular function under hyperglycemic conditions was assessed using scratch assays, Transwell migration assays, qRT-PCR, and western blotting. Furthermore, approved by the Institutional Animal Care and Use Committee of the affiliated institution, a diabetic C57BL/6J mouse skin defect model was established and divided into three groups: an NC group (normal mice control), Glu group (diabetic model control), and PEG-STG group (treated with PEG-STG hydrogel in situ). Wound healing was evaluated through gross observation, wound healing rate analysis, and histological assessment via H&E staining. Results The PEG-STG hydrogels exhibited rapid gelation at room temperature, excellent injectability, and a uniform porous structure. Compared with the PEG hydrogels, the PEG-STG hydrogels showed a significantly increased maximum compressive strength, swelling ratio, and degradation rate (P < 0.05). In vitro release profiles indicated an initial burst release of STG followed by a sustained release phase. Biocompatibility assessments confirmed that the PEG-STG hydrogels possessed good cytocompatibility and hemocompatibility. In vitro cellular experiments demonstrated that high glucose significantly inhibited the migration of the HUVECs and L929 cells, which was not ameliorated by the PEG group but was notably improved by the PEG-STG group. Moreover, the PEG-STG hydrogels upregulated the mRNA expression levels of platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31), vascular endothelial growth factor (VEGF), and von Willebrand factor in HUVECs, along with increased protein expression of VEGF and CD31. In vivo results revealed that at 14 days post-operation, the PEG-STG group exhibited significantly enhanced wound closure compared with the Glu and NC groups. H&E staining showed improved re-epithelialization, increased granulation tissue formation, and better tissue structure restoration in the PEG-STG group. Conclusion PEG-STG hydrogels possess favorable injectability and biocompatibility. They can improve endothelial cell and fibroblast function under hyperglycemic conditions and promote diabetic skin wound healing, providing a experimental basis for developing localized therapeutic materials for oral and maxillofacial wounds in patients with diabetes.

Objective To investigate the effects of curcumin on the biological behavior of oral squamous cell carcinoma (OSCC) cells and its potential molecular mechanisms, as well as to provide experimental evidence for the application of curcumin in the prevention and treatment of OSCC. Methods All animal experiments in this study were approved by the Institutional Animal Welfare and Ethics Committee and strictly adhered to relevant animal ethics guidelines. Potential intersecting targets of curcumin and OSCC were screened using TCMSP, SwissTargetPrediction, DrugBank, and GeneCards databases, followed by construction of a protein-protein interaction network and gene ontology(GO) /Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Scratch and clone formation experiments were conducted using CAL-27 and SCC-9 cells to detect the effect of curcumin on cell migration and proliferation ability. Combining RNA sequencing analysis of differentially expressed genes, and verifying the changes in mRNA and protein expression of key cellular molecules by curcumin through real-time fluorescence quantitative PCR and Western blot, respectively. Simultaneously establish a CAL-27 xenograft BALB/c nude mouse transplant tumor model and use immunohistochemistry to detect the effect of curcumin treatment on the expression of related proteins in the transplant tumor tissue. Results A total of 178 intersecting targets were identified, mainly enriched in the PI3K/AKT signaling pathway and lipid metabolism-related pathways. Curcumin significantly inhibited migration and colony formation of CAL-27 and SCC-9 cells in vitro. Transcriptomic analysis identified 828 differentially expressed genes enriched in lipid metabolism and PI3K/AKT pathways. Real-time fluorescence quantitative PCR showed downregulation of PIK3CA, CCND1, BCL2, and FASN, while western blot demonstrated decreased expression of p-AKT and FASN. In vivo, curcumin markedly suppressed tumor growth and reduced the expression of Ki-67, BCL2, and p-AKT in tumor tissues. Conclusion Curcumin may inhibit the migration and proliferation of OSCC cells by regulating the PI3K/AKT signaling pathway and the expression of lipid metabolism-related genes.

Objective To investigate the bactericidal efficacy and impact on oral mixed biofilm microbial structure of commonly used clinical root canal irrigants under dynamic oxygen conditions, and to provide experimental evidence for clinical root canal irrigant selection. Methods This study has been reviewed and approved by the Medical Ethics Committee, and written informed consent has been obtained from all of the participants. Two healthy oral volunteers from Beijing Stomatological Hospital, Capital Medical University were selected, and subgingival and supragingival plaque from their mandibular premolars and molars were extracted to construct an oral mixed microbial biofilm model. The plaque was cultivated on hydroxyapatite slices for 1 week (anaerobic conditions for 3 days + aerobic conditions for 4 days) to construct a young oral mixed bacterial biofilm model, and cultivated for 3 weeks (anaerobic conditions for 3 days + aerobic conditions for 18 days) to construct a mature oral mixed bacterial biofilm model. Three root canal irrigating solutions were used: sterile water (control), 2% chlorhexidine (CHX), and 1% sodium hypochlorite (NaOCl). The bacterial biofilms were treated for 1 week and 3 weeks, respectively, and the overall bactericidal rate was assessed using live/dead bacterial staining and laser confocal microscopy. Concurrently, high-throughput 16S rRNA sequencing was performed to analyze the microbial community structure and to evaluate the antibacterial effects of irrigation solution, on common dominant pathogens. Results The proportion of dead bacteria in the biofilm treated with three types of root canal irrigation drugs at 1 week and 3 weeks, from high to low, were as follows: 1% NaOCl >2% CHX >control group (P < 0.001). The bactericidal rate of 1% NaOCl on mature biofilms at 3 weeks was significantly lower than that of light biofilms at 1 year (P < 0.001). High-throughput sequencing revealed minimal effects of 2% CHX and 1% NaOCl on biofilm community structure but demonstrated poor bactericidal activity against dominant root canal pathogens, such as Streptococcus and Fusobacterium. Conclusion Under the initial anaerobic and subsequent aerobic culture conditions, 1% NaOCl exhibits potent bactericidal effects on young bacterial biofilms, but demonstrates limited efficacy against mature biofilms and certain root canal dominant bacteria (Streptococcus and Fusobacterium).

Bacterial extracellular vesicles (BEVs) are nanoscale, lipid bilayer-enclosed vesicles that are actively or passively released by bacteria. They carry diverse bioactive cargos, including proteins, nucleic acids, and lipids, and mediate information exchange between microbial communities and hosts. Increasing evidence indicates that BEVs play important roles in the initiation and progression of dental caries and periodontitis. In dental caries, BEVs derived from cariogenic bacteria such as Streptococcus mutans can promote biofilm formation and maturation, enhance the acidic microenvironment, and exacerbate demineralization of dental hard tissues. In periodontitis, BEVs released by key periodontal pathogens, including Porphyromonas gingivalis and Fusobacterium nucleatum, may disrupt the mucosal barrier, trigger inflammatory responses, and activate bone resorption-related pathways, thereby promoting periodontal tissue destruction. Owing to their detectability, BEVs in oral samples such as saliva, dental plaque, and gingival crevicular fluid show promise as diagnostic biomarkers and also provide new therapeutic opportunities for targeted interventions. In addition, emerging studies suggest that oral BEVs may contribute to distal inflammatory amplification through an “oral-systemic axis”; therefore, while focusing on the local pathogenic mechanisms of BEVs in dental caries and periodontitis, this review also briefly outlines their potential systemic implications as an extension. Overall, BEVs may offer novel mechanistic insights and translational directions to support precise prevention and management of dental caries and periodontitis.

Mandibular condylar fractures are common injuries in oral and maxillofacial surgery. The unique anatomical structure and mechanical environment of the condyle render its fracture healing process distinct from that of long bones. Parathyroid hormone (PTH) and its active fragment PTH(1-34) (such as the drug teriparatide) are among the few clinically available agents with bone-anabolic properties, and have shown promise in fracture repair. However, the anatomical and mechanical discrepancies between the condyle and long bones raise doubts as to whether the efficacy of PTH observed in long bones can be directly extrapolated to condylar fractures. Elucidating how mechanical loading modulates the bone remodeling effects of PTH within the specific mechanical environment of the mandibular condyle thus constitutes a critical entry point for addressing this question. This review summarizes recent advances regarding how mechanical loading influences PTH-promoted healing of mandibular condylar fractures from three perspectives: the mechanical sensitivity of condylar fracture healing, the molecular mechanisms by which PTH regulates bone remodeling, and the synergy between mechanical and pharmacological interventions, with the aim of clarifying the existing molecular evidence for mechanical-PTH synergy derived from long-bone and in vitro models, and critically evaluating the feasibility and limitations of extrapolating these findings to condylar fractures. Evidence from long-bone fracture models and in vitro mechanical loading systems indicates that mechanical loading modulates the direction of PTH-mediated bone remodeling through the receptor activator of the nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis and the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/glycogen synthase kinase-3β (GSK3β)/nuclear factor of the activated T-cells c1 (NFATc1) pathway, an effect that exhibits marked intensity- and time-dependent characteristics. Nevertheless, critical challenges remain in this field, including the standardization of quantitative mechanical loading parameters, the accumulation of direct evidence from condyle-specific fracture models, and the in-depth elucidation of the regulatory mechanisms governing mechanical-drug synergy. Future research should integrate finite element analysis, standardized mechanical loading techniques, and single-cell omics to establish a quantitative relationship between mechanical parameters, cellular responses, and PTH effects, thereby providing a theoretical basis for optimizing postoperative masticatory load management and PTH administration strategies in condylar fractures.

Adenoid hypertrophy is one of the most common causes of upper airway obstruction in children, often presenting with nasal congestion as the initial symptom and accompanied by a series of related manifestations. Due to impaired nasal ventilation, affected children are forced into compensatory mouth breathing. This altered breathing pattern modifies the upper airway fluid environment, leading to abnormal changes in airflow velocity, pressure distribution, and flow patterns. Prolonged mouth breathing disrupts the dynamic equilibrium of perioral musculature, thereby interfering with normal maxillofacial growth and development and contributing to the occurrence of malocclusion. Upper airway fluid mechanics, developed through the integration of computational fluid dynamics (CFD) technology and medical imaging, serves as a quantitative analytical tool capable of precisely characterizing airflow velocity, pressure distribution, and flow patterns within anatomically complex structures such as the nasal cavity and pharynx. By leveraging multidimensional fluid mechanical parameters, this approach can accurately depict the flow field characteristics of the upper airway in patients with adenoid hypertrophy, clearly illustrating the relationship between airway anatomy and ventilatory function, and providing objective quantitative evidence for disease assessment. In clinical practice, CFD enables the evaluation of how different interventions improve airway ventilation, allowing scientific prediction and objective assessment of therapeutic outcomes. Nevertheless, several critical challenges remain, including the lack of standardized protocols for upper airway modeling and boundary condition definition, insufficient understanding of the dynamic relationship between fluid mechanical parameters and the progression of malocclusion severity, and the predominance of cross-sectional study designs with limited longitudinal data on pre- and post-intervention flow field changes, which restricts the translation of simulation results into actionable clinical indicators. In the future, with the establishment of standardized simulation workflows and the conduct of large-scale prospective cohort studies, upper airway fluid mechanics is expected to integrate with artificial intelligence and multimodal imaging technologies to develop intelligent decision-support systems, thereby advancing the scientific rigor and personalization of diagnosis and treatment for adenoid hypertrophy and associated malocclusion.

Objective The present study aimed to evaluate the clinical efficacy of hydraulic sinus floor elevation for the treatment of insufficient bone height in the posterior maxilla through a systematic review and Meta-analysis, so as to provide evidence for clinical practice. Methods Databases including PubMed, Embase, Cochrane Library, and Clinical Trials.gov were searched up to May 2025. Randomized controlled trials, non-randomized controlled trials, cohort studies, cross-sectional studies, and case-control studies that involved patients receiving hydraulic sinus floor elevation with simultaneous or delayed implant placement were included. Exclusion criteria comprised in vitro studies, animal experiments, narrative reviews, unpublished data, commentaries or expert opinions, studies with unclear sample sizes, and publications without full-text access or unavailable outcome data. Three investigators independently performed literature screening and quality assessment. A single-arm Meta-analysis was conducted using Stata 18.0 for studies meeting the inclusion criteria. The outcome measures were the incidence of sinus membrane perforation, implant survival rate, and endo-sinus bone gain. The Cochrane Risk of Bias 2 (RoB2) tool and the Joanna Briggs Institute (JBI) critical appraisal checklist were used to assess the methodological quality of randomized controlled trials and non-randomized controlled trials, respectively. The overall certainty of evidence was assessed using the GRADE（Grading of Recommendations Assessment, Development and Evaluation）system. Results Nineteen studies with 982 patients, 1 151 elevated sites, and 1 263 implants were finally included. The Meta-analysis showed that the intraoperative sinus membrane perforation rate of hydraulic sinus floor elevation was 2.0% [ES = 0.02, 95% CI (0.00, 0.04)] (18 studies, 1 061 sites); the implant survival rate was 99.0% [ES = 0.99, 95% CI (0.97, 1.00)] (17 studies, 1 253 implants); and the mean vertical bone gain was 7.80 mm. For this outcome, heterogeneity among studies was extremely high (I² = 98.6%), thus only descriptive analysis was performed. Egger's test revealed no significant publication bias for the three outcomes. GRADE grading indicated very low certainty of evidence for mucosal perforation, implant survival rate, and endo sinus bone gain. Conclusion Current preliminary evidence suggests that hydraulic sinus lift may be a safe minimally invasive technique, but the evidence is very low, and more high quality, long term follow up randomized controlled clinical trials are still needed for further verification.